TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Frequency of PAC about sexual health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of PAC about alcohol use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of wound problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hard clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater intra-bony defect fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom reductions as measured by clinical assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RSV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of wheezing episodes
Endpoint domain: Adverse events/effects
Primary endpoint: VAS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HWES score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in disability (FIM motor domain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental composite score of health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 3-year survival following extended gastrectomy for T4b adenocarcinoma
Endpoint domain: Mortality/survival
Primary endpoint: median survival following extended gastrectomy for T4b adenocarcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Duration of AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Daily mean urine output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: median response time in milliseconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Possible sustained unresponsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rectal tolerated volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Acquisition of novel morpheme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ki-67 indices in initial biopsy and resection specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: height SD score for age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: predicted adult height SD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: target nail score decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total score decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pediatric obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of missing data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Loss of sensation to pin prick, light touch and cold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right atrial area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Complete response rate in delayed phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pill-bottle adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical pain subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handicap subscale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Social activities
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mean visual analogue score for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of analgesic treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 30-second chair stands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: multidimensional balance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time from sensory disturbance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: post-operative sore throat
Endpoint domain: Adverse events/effects
Primary endpoint: hypersensitivities reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in office BP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Average daily adherence to medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Budget impact of ocriplasmin
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relief in angina symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to chest pain during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Cholesterol (TChol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Triglycerides (TGs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: nausea scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Final graft take percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with bleeding stopped within 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of bleeding-free interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean duration of bleeding days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative survival percentages of single-surface non-occlusal ART restorations
Endpoint domain: Mortality/survival
Primary endpoint: duration of stage 2 sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of slow-wave sleep (stage 4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of paradoxical (rapid eye movement) sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) function pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: triple response rate in HBeAg-positive patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: combined response rate in HBeAg-negative patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of response at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Likelihood of remission at follow-up
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Routine costs for telephone follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Travel and productivity costs for hospital-based follow-up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of caries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diastolic Filling Rate (DFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Ventricular Emptying Rate (LVER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Catheter obstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Pump malfunction
Endpoint domain: Adverse events/effects
Primary endpoint: CMV-IgM negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CMV-DNA negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of life (QOL) outcomes
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean duration of caudal analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: supplemental analgesia requirements with pethidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of behavioral side effects
Endpoint domain: Adverse events/effects
Primary endpoint: mean number of bleeding days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time until amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm ability to penetrate synthetic medium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Sperm velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Duration of progressive motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: visual analog scale pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical activity scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: quality of sleep scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: NPSAE occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Quit rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Percentage of cats free of nematode ova after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean faecal egg count reduction for T. cati
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dye attachment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total morphine consumption (morphine equivalents)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average reported pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: utilization of voluntary counseling and testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Left ventricular end-systolic diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CSBS standard scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lightening of melasma (MASI score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pigmentation measurements (MAMI score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Agreement on low cardiac output syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ICU readmission rate
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: health care costs incurred
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: lower relapse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erectile function improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Pain or discomfort on ejaculation relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in thigh skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in superficial muscle temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in deep muscle temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal walking speed (10MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean tremor severity scale scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tHcy concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Time to delivery (TSL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: error rate (ER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BDI residual gain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's knee preference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Difficulties with everyday activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Cognitive and behavioral status
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: ACE total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental health problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: substance use problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single Assessment Numeric Evaluation scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical failures
Endpoint domain: Adverse events/effects
Primary endpoint: Mean loss of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived risk improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer-related stress reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean count of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Size of sebaceous glands
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Agreement with standard definition of improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leg pain resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to achieve or maintain an erection sufficient for satisfactory sexual performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean lung volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean tracheal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time required for wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patterns of use of effective contraceptives
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of switching to a more or less effective method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of low-back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bond strength of adhesive resin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative hospital stay duration
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Shoulder passive range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of emergency contraception (EC) repeatedly
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hands-on time within the first 180 seconds after cardiac arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: individual risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: continuous risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in bone mass and bone formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skeletal morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: paradoxical hypertrichosis
Endpoint domain: Adverse events/effects
Primary endpoint: high IgE‐associated atopic eczema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tolerability and safety of carvedilol CR
Endpoint domain: Adverse events/effects
Primary endpoint: Proportions of patients completing doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disabilities of the Arm, Shoulder and Hand scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of postoperative vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Time to first oral intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of IV therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of having an accident requiring a hospital visit
Endpoint domain: Mortality/survival
Primary endpoint: Completion of Haemophilus influenzae b immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Completion of polio immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of examined lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Proportion of patients with ≥12 lymph nodes examined
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: CIPN scores at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Grade 3 to 4 neurotoxicity frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Mean operating time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Postoperative pad test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of sub-surface caries lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood elevation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in chasing behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in stranger-directed fear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-care adherence
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Signs and symptoms of dry eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-normal or high diastolic BP (DBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High-normal or high systolic BP (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: disappearance of varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of hematoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematoma enlargement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum walking speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of high quality chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average rate of compressions per minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of chest compressions within guideline rate recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APACHE-II score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD3+ levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in vestibular tenderness score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cognitive decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive scores at discharge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive scores at 1 month after discharge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total effective rate on disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of CD62 P
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma levels of ICAM‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of acne lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global improvement of acne severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance (erythema, dryness, desquamation, stinging/burning)
Endpoint domain: Adverse events/effects
Primary endpoint: CD4+ count differences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to First Intervention (TFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐rated quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sputum eosinophil percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sputum total cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sputum ECP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes